WHY IS CLOZAPINE MORE EFFECTIVE THAN OTHER ATYPICAL ANTIPSYCHOTICS? DENSITY FUNCTIONAL THEORY AND MOLECULAR DOCKING APPROACH

Öz

In order to find some clues as to why clozapine is a more effective drug than the sertindole and quetiapine, we investigated the molecular structures of these three molecules and calculated their structural properties by Density Functional Theory (DFT) technique. In this article, we suggested that clozapine has different binding possibilities depending on the dopamine level in the medium. If so, it can be understood why clozapine is more effective in resolving clinical problems caused by different dopamine levels in the frontal and subcortical regions. To test this hypothesis, we measured the binding of three drugs to D₁ and D₂ dopamine receptors by molecular docking. We found that clozapine had a greater potential for binding with D₁ and D₂ receptors. We suggested that this feature might give clozapine a higher therapeutic effect.

Anahtar Kelimeler

• Dopamine,molecular docking,clozapine,schizophrenia

Kaynakça

1. 1. Aranda R., Villalba K., Ravina E., Masaguer C.F., Brea J., Areias F., Dominguez E., Selent J., Lopez L., Sanz F., Pastor M. & Loza M.I. (2008). Synthesis, Binding Affinity, and Molecular Docking Analysis of New Benzofuranone Derivatives as Potential Antipsychotics. J. Med. Chem., 51(19), 6085-6094.
2. 2. Arnt J., Hyttel J. & Sánchez C. (1992). Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. European Journal of Pharmacology, 213(2), 259–267.
3. 3. Bayri A., Unal S., Altin S., Bulut F. & Dayanc B. E. (2016). Altered isotope charge distribution of acetylcholine neurotransmitter and Myasthenia Gravis. Medical Hypotheses, 89, 84–88.
4. 4. Becke A. D. (1993). A new mixing of Hartree–Fock and local density‐functional theories. The Journal of Chemical Physics, 98(2), 1372–1377.
5. 5. de Keyser J., De Backer J.-P., Vauquelin G. & Ebinger G. (1990). The effect of aging on the D1 dopamine receptors in human frontal cortex. Brain Research, 528(2), 308–310.
6. 6. Devoto P., Flore G., Vacca G., Pira L., Arca A., Casu M. A., Pani L. & Gessa G. L. (2003). Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology, 167(1), 79–84.
7. 7. Khokhar J. Y., Henricks A. M., Sullivan E.D.K. & Green A.I. (2018). Unique Effects of Clozapine: A Pharmacological Perspective. Advances in Pharmacology (San Diego, Calif.), 82, 137–162.
8. 8. Lee C., Yang W. & Parr R. G. (1988). Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Physical Review B, 37(2), 785–789.

9. 9. Perreault M. L., O’Dowd B.F. & George S.R. (2011). Dopamine receptor homooligomers and heterooligomers in schizophrenia. CNS Neuroscience & Therapeutics, 17(1), 52–7.
10. 10. Qin S., Hermans E. J., van Marle H.J.F., Luo J. & Fernández G. (2009). Acute Psychological Stress Reduces Working Memory-Related Activity in the Dorsolateral Prefrontal Cortex. Biological Psychiatry, 66(1), 25–32.
11. 11. Salmas R.E., Is Y.S., Durdagı S., Stein M. & Yurtsever M. (2018). A QM protein–ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R). Journal of Biomolecular Structure and Dynamics, 36, 2668-2677.
12. 12. Siskind D., McCartney L., Goldschlager R. & Kisely S. (2016). Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry, 209(05), 385–392.
13. 13. Tauscher J., Hussain T., Agid O., Verhoeff N.P.L.G., Wilson A. A., Houle S., Remington G., Zipursky R.B. & Kapur S. (2004). Equivalent Occupancy of Dopamine D 1 and D 2 Receptors With Clozapine: Differentiation From Other Atypical Antipsychotics. American Journal of Psychiatry, 161(9), 1620–1625.
14. 14. Thomas T., Fang Y., Yuriev E. & Chalmers D. (2016). Ligand Binding Pathways of Clozapine and Haloperidol in the Dopamine D2 and D3 Receptors. J. Chem. Inf. Model., 56(2), 308-321.
15. 15. URL-1 (2019). https://pubchem.ncbi.nlm.nih.gov/compound, National Center for Biotechnology Information. PubChem Database.
16. 16. Yang W., Parr R. G. & Lee C. (1986). Various functionals for the kinetic energy density of an atom or molecule. Physical Review A, 34(6), 4586–4590.